Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+3.2%
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
+3.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202437.94%
202311.77%
2022-58.74%
202134.51%
20201.62%
2019-144.95%
2018-160.27%
20170.00%